Ardelyx (NASDAQ:ARDX – Get Free Report)‘s stock had its “outperform” rating reaffirmed by stock analysts at Wedbush in a research note issued to investors on Friday, Benzinga reports. They currently have a $15.00 price target on the biopharmaceutical company’s stock. Wedbush’s price target would indicate a potential upside of 122.22% from the company’s previous close. […]
TCW Group Inc. boosted its holdings in shares of LXP Industrial Trust (NYSE:LXP – Free Report) by 4.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 137,722 shares of the real estate investment trust’s stock after purchasing an additional 6,309 […]
Act Two Investors LLC purchased a new stake in Motorola Solutions, Inc. (NYSE:MSI – Free Report) during the 4th quarter, Holdings Channel reports. The firm purchased 874 shares of the communications equipment provider’s stock, valued at approximately $274,000. Other large investors have also modified their holdings of the company. Qube Research & Technologies Ltd grew […]
Swiss National Bank boosted its holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 17.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 228,500 shares of the company’s stock after acquiring an additional 34,600 shares during the quarter. Swiss National Bank owned […]
Davis R M Inc. bought a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 492 shares of the pharmaceutical company’s stock, valued at approximately $200,000. A number of other hedge funds and […]